Robin Schubert

Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study

Ralf Reilmann, Andrew McGarry, Igor D. Grachev et al. · The Lancet Neurology · 2018 · 108 citations

Medicine, Neurology, Pharmacology +10

Gait variability as digital biomarker of disease severity in Huntington’s disease

Heiko Gaßner, Dennis Jensen, Franz Marxreiter et al. · Journal of Neurology · 2020 · 58 citations · Full text

Medicine, Neurology, Neuroscience +17

Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study

Ralf Reilmann, Karen E. Anderson, Andrew Feigin et al. · The Lancet Neurology · 2024 · 33 citations · Full text

Medicine, Neurology, Pharmacology +7

Neuroimaging of a minipig model of Huntington's disease: Feasibility of volumetric, diffusion-weighted and spectroscopic assessments

Robin Schubert, F. Frank, Nina Nagelmann et al. · Journal of Neuroscience Methods · 2015 · 23 citations

Medicine, Neurology, Neuroscience +14

Physical activity and exercise outcomes in Huntington's disease (PACE-HD): results of a 12-month trial-within-cohort feasibility study of a physical activity intervention in people with Huntington's disease

Lori Quinn, Rebecca Playle, Cheney Drew et al. · Parkinsonism & Related Disorders · 2022 · 23 citations · Full text

Medicine, Rehabilitation Medicine, Falls Prevention +16